These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 14587387

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Comparative analysis of the proliferative capacity of cholesteatomas].
    Bernal Sprekelsen M, Ebmeyer J, Buchbinder A, Sudhoff H.
    Acta Otorrinolaringol Esp; 2000 May; 51(4):299-307. PubMed ID: 10984952
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Expression of epidermal growth factor receptor Ki67 and p16 in human middle ear cholesteatoma].
    Li S, Zhan H, Peng S.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Nov; 22(21):987-91. PubMed ID: 19157151
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Up-regulation of neutrophil gelatinase-associated lipocalin in cholesteatoma.
    Woo HJ, Park JC, Bae CH, Song SY, Lee HM, Kim YD.
    Acta Otolaryngol; 2009 Jun; 129(6):624-9. PubMed ID: 18720059
    [Abstract] [Full Text] [Related]

  • 31. Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear.
    Schilling V, Negri B, Bujía J, Schulz P, Kastenbauer E.
    Am J Otol; 1992 Jul; 13(4):350-5. PubMed ID: 1384343
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Immunohistochemical analysis of the cytokeratin expression in middle ear cholesteatoma and related epithelial tissues.
    Broekaert D, Coucke P, Leperque S, Ramaekers F, Van Muijen G, Boedts D, Leigh I, Lane B.
    Ann Otol Rhinol Laryngol; 1992 Nov; 101(11):931-8. PubMed ID: 1280020
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Interleukin-1-containing cells in cholesteatoma of the middle ear].
    Schilling V, Bujia J, Negri B, Kastenbauer E.
    Laryngorhinootologie; 1992 May; 71(5):271-5. PubMed ID: 1616549
    [Abstract] [Full Text] [Related]

  • 37. Fascin expression in cholesteatoma: correlation with destruction of the ossicular chain and extent of disease.
    Binnetoglu A, Sari M, Baglam T, Erbarut Seven I, Yumusakhuylu AC, Topuz MF, Batman C.
    Clin Otolaryngol; 2015 Aug; 40(4):335-40. PubMed ID: 25581788
    [Abstract] [Full Text] [Related]

  • 38. Antigen expression of epithelial markers, collagen IV and Ki67 in middle ear cholesteatoma. An immunohistochemical Study.
    Ergün S, Zheng X, Carlsöö B.
    Acta Otolaryngol; 1994 May; 114(3):295-302. PubMed ID: 7521107
    [Abstract] [Full Text] [Related]

  • 39. [Clinical and pathological features of cholesteatoma in young children].
    Skotnicka B, Hassmann-Poznańska E.
    Otolaryngol Pol; 2010 May; 64(6):375-81. PubMed ID: 21302505
    [Abstract] [Full Text] [Related]

  • 40. Telomerase activity and cell proliferation index in cholesteatoma.
    Lee SH, Jang YH, Tae K, Park YW, Kang MJ, Kim KR, Park CW.
    Acta Otolaryngol; 2005 Jul; 125(7):707-12. PubMed ID: 16012031
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.